'If the Patient Information Leaflet that comes with your medication says to avoid grapefruit juice, for instance, then do not take CBD, as the same type of interaction can affect circulating blood levels of your medicine. Even if the leaflet does not mention grapefruit juice, you should still check with your doctor before taking CBD. You should also not take CBD if you are pregnant or breastfeeding.’
Another major reason why CBD oil has been positively received in some parts of the medical community is its apparent effect on cancer and tumor growth.A study done by the researchers of the Institute of Toxicology and Pharmacology, University of Rostock, Germany recommends the use of CBD oil (even direct injection into tumors) to eliminate or reduce the size of the tumors. The antioxidants in CBD hemp oil also provide anti-mutagenic properties and lower users’ risk of cancer.
It probably depends on each individual’s preference, but many researchers support the effects of the full spectrum CBD. They say that the full spectrum’s healing factors through the “entourage effect” are very useful for the treatment of any of the chronic condition. This is why the full spectrum CBD has to be part of the ingredients, not the isolate non-pure one.
Along with its better-known counterpart, THC (delta-9-tetrahydrocannabinol, the chemical that produces the marijuana high), CBD is one of more than 400 compounds found in the oils of cannabis plant species, which include marijuana and hemp. Unlike THC, CBD will not make you high. That said, this doesn’t mean CBD is not at all psychoactive, as many assert, says Jahan Marcu, Ph.D., director of experimental pharmacology and behavior at the International Research Center on Cannabis and Mental Health in New York City: “CBD does change cognition. It affects mood, which is why people take it for anxiety. And some find that it makes them more alert.”
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160